Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1

Status

Completed 3Withdrawn 2Unknown 2Terminated 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Surgical Wound Infection 1Sepsis 1Neutropenia 1Neoplasms 1Colonic Neoplasms 1

Interventions

Cyclophosphamide 390Carboplatin 343Gemcitabine 331pembrolizumab 330Cisplatin 327Paclitaxel 295Radiotherapy 292Docetaxel 286Bevacizumab 249Rituximab 233Capecitabine 222Nivolumab 220Dexamethasone 205Fluorouracil 189fludarabine 178Oxaliplatin 177Pemetrexed 153Doxorubicin 152Irinotecan 147Etoposide 144Leucovorin 143Cytarabine 134fludarabine phosphate 129Bortezomib 129Cetuximab 127Lenalidomide 125Filgrastim 120Erlotinib Hydrochloride 119Temozolomide 111Ipilimumab 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Interventional × Gentamicins × Clear all
NCT03475680 2022-05-17

COLONPREP

Assistance Publique - Hôpitaux de Paris

Phase 3 Terminated
193 enrolled
Gastrointestinal

Colonic Neoplasms, Surgical Wound Infection

NCT01931592 2017-05-08

CLEAR

University of Cologne

Phase 2/3 Terminated
29 enrolled

Neoplasms, Neutropenia, Sepsis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡